Prostate cancer screening in Brazil: should it be done or not?

Prostate cancer screening in Brazil: should it be done or not?

ABSTRACT The use of PSA in the screening, detection and prognosis of prostate cancer (PCa) has revolutionized the diagnosis and treatment of this disorder with an increase in detection rates and PCa organ-confined. Despite these benefits and ease of implementation, tracking PCa remains a matter of g...

Full description

Bibliographic Details
Main Authors:	Wilson F. S. Busato Jr., Gilberto L. Almeida
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia
Series:	International Brazilian Journal of Urology
Subjects:	Prostatic Neoplasms Mass Screening Brazil
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601069&lng=en&tlng=en

Similar Items

A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
by: Fernando Antônio Glasner da Rocha Araújo, et al.

Association between Literacy, Compliance with Prostate Cancer Screening, and Cancer Aggressiveness: Results from a Brazilian Screening Study
by: Marcos Tobias-Machado, et al.
Published: (2013-06-01)

Influence of repeated prostate-specific antigen screening on treatment pattern in a country with a limited social perception of prostate cancer: Korean national wide observational study
by: Young Hwii Ko, et al.
Published: (2021-05-01)

Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
by: Rafael Ribeiro Mori, et al.
Published: (2019-01-01)

Can natural killer cell activity help screen patients requiring a biopsy for the diagnosis of prostate cancer?
by: Bum Sik Tae, et al.
Published: (2020-02-01)

The impact of socioeconomic status on prostate cancer screening and access to medical care
by: Seyed Zadeh, et al.
Published: (2022-12-01)

Prostate cancer awareness in the city of São Paulo
by: Feres Camargo Maluf, et al.
Published: (2021-12-01)

Prostate Cancer Screening and Health Beliefs: A Turkish Study of Male Adults
by: Naile Bilgili, et al.
Published: (2019-05-01)

Association between PSA values and surveillance quality after prostate cancer surgery
by: Christina Hunter Chapman, et al.
Published: (2019-12-01)

Decision aid for prostate cancer screening in Brazil
by: Renata Oliveira Maciel dos Santos, et al.
Published: (2022-04-01)

Prostate Cancer Screening in Brazil: a single center experience in the public health system
by: Renato Almeida Rosa de Oliveira, et al.
Published: (2021-03-01)

Prostate Cancer Predicting Factors A Preliminary Report from Tehran
by: Gholamreza Pourmand, et al.
Published: (2012-11-01)

Trend and spatial analysis of prostate cancer mortality in the state of Sergipe, Brazil
by: José Augusto Passos Góes, et al.
Published: (2018-11-01)

A 10-year analysis of metastatic prostate cancer as an initial presentation in an underserved population
by: Andrew G. Winer, et al.
Published: (2014-06-01)

Australian patterns of prostate cancer care: Are they evolving?
by: Jonathon Lo, et al.
Published: (2016-03-01)

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening
by: Yasuhide Kitagawa, et al.
Published: (2013-06-01)

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
by: Kerri Beckmann, et al.
Published: (2019-08-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
by: Jae-Seung Chung, et al.
Published: (2020-09-01)

Trends in prostate cancer research /
by: Lucas, John N.
Published: (2005)

Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions
by: Shahram Shahangian, et al.
Published: (2021-08-01)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
by: J. Zhang, et al.
Published: (2016-01-01)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
by: J. Zhang, et al.
Published: (2016-07-01)

Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer
by: Atsushi Ikeda, et al.
Published: (2015-09-01)

Use of the prostate‐specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions
by: Shahram Shahangian, et al.
Published: (2021-08-01)

A Ten-Year Study of Prostate Cancer: A Southern Iranian Experience
by: Mehrzad Lotfi, et al.
Published: (2018-07-01)

Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01)

Prostate cancer detected by screening in a semi urban community in Southeast Nigeria: Correlations and associations between anthropometric measurements and prostate-specific antigen
by: Fred O Ugwumba, et al.
Published: (2017-01-01)

Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
by: Jong-Myon Bae
Published: (2015-03-01)

Impact of lifestyle in prostate cancer patients. What should we do?
by: Herney Andrés García-Perdomo, et al.
Published: (2022-03-01)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
by: Tushar Aditya Narain, et al.
Published: (2022-01-01)

A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study
by: Mauritz Waldén, et al.
Published: (2022-04-01)

A new approach to prostate cancer screening
by: Filella Xavier, et al.
Published: (2023-08-01)

Does a family history of prostate cancer affect screening behavior in Jamaican men?
by: Belinda F. Morrison, et al.
Published: (2018-11-01)

Teledermatology protocol for screening of Skin Cancer
by: Maria Fernanda Piccoli, et al.
Published: (2015-04-01)

Should Contemporary Western Guidelines Based on Studies Conducted in the 2000s Be Adopted for the Prostate-Specific Antigen Screening Policy for Asian Men in the 2020s?
by: Young Hwii Ko, et al.
Published: (2022-10-01)

Changes in cancer screening before and during COVID‐19: findings from the Korean National Cancer Screening Survey 2019 and 2020
by: Thao Thi Kim Trinh, et al.
Published: (2022-05-01)

Comparative Analysis of Proteomes and Phosphoproteomes in Patients with Prostate Cancer Using Different Surgical Conditions
by: Hee-Sung Ahn, et al.
Published: (2022-10-01)

Performance of free prostate-specific antigen ratio in differentiating between prostatic cancer and benign prostatic lesions at a referral hospital in South Africa
by: Boitumelo Phiri-Ramongane, et al.
Published: (2018-08-01)